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Abstract
Objective: To study the etiology of short stature in children in eastern 
Taiwan.
Materials and Methods: This retrospective study included patients 
referred to Hualien Buddhist Tzu Chi General Hospital for evaluation of 
short stature from 2002 to 2008. Data were collected from medical 
records, and included body height and weight by percentile, maternal his-
tory, birth history, past medical history, relevant hematological and bio-
chemical investigations, urinalysis, levels of growth and thyroid hormones, 
bone age, and genetic study.
Results: A total of 139 children were enrolled. Sixty (43.2%) were classi-
fied as having idiopathic short stature, 48 (34.5%) were attributed to 
underlying disease such as gastrointestinal disorder or chronic illness, 14 
(10.1%) had been small for gestational age at birth and their growth had 
not caught up with that of their peers, 11 (7.9%) were diagnosed with 
familial short stature, and 6 (4.3%) were diagnosed with growth hormone 
deficiency.
Conclusion: Idiopathic short stature was the most common etiology of 
short stature in children in eastern Taiwan. The incidence of short stature 
attributed to underlying disease seems to be higher than in other areas 
of Taiwan. The percentage of small-for-gestational-age children without 
catch-up growth was also higher in eastern Taiwan than in other areas. 
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1. Introduction
Short stature is a common health care issue with di-
verse etiologies. It causes not only physical but also 
psychological problems in children [1]. Identifying the 
underlying etiology is crucial for early prevention and 
treatment.
The population of eastern Taiwan has a relatively 
diverse ethnic background and many people are from 
the lower socioeconomic classes. Health care resources 
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(55.4%) were diagnosed before the age of 6 years. 
The five main categories of short stature are listed in 
Table 1. ISS was diagnosed in 60 (43.2%) cases and 
was the most common cause of short stature in east-
ern Taiwan.
Forty-eight (34.5%) children were found to have 
underlying disease (Table 2). Among them, 23 cases 
were associated with neuromuscular disorders, includ-
ing epilepsy and cerebral palsy. Four children were 
diagnosed with malnutrition, three with iron deficiency 
anemia and one with zinc deficiency. Four children 
had chromosomal anomalies, including two with Down 
syndrome, one with fragile X syndrome, and one with 
microdeletion of chromosome 3p. Four children were 
are often located far from patients’ homes. The etiol-
ogy of short stature may be different from that in other 
parts of Taiwan. The aim of this study was to investi-
gate the etiology of short stature in children in eastern 
Taiwan.
2. Materials and methods
Subjects who were diagnosed with short stature (ICD-9 
code “784.3: lack of normal physiological develop-
ment”) in the outpatient clinic of Hualien Buddhist 
Tzu Chi General Hospital between January 2002 and 
April 2008 were included. Short stature is defined as 
a body height under the 3rd percentile according to 
the growth chart [2]. Subjects were excluded if they 
had fewer than three outpatient follow-ups, had purely 
psychomotor delay, or had been small for gestational 
age (SGA) at birth but had caught up to their peers 
by the age of 2 years. Analytic data included age at 
diagnosis, maternal history, birth history, past medi-
cal history, sequential body height and weight growth 
at different ages, bone age, and laboratory data in-
cluding complete blood count, biochemistry study, 
hormone tests, urinalysis, and karyotyping.
Etiology was categorized into five major groups: 
normal variants of growth; SGA without catch-up 
growth; hormone deficiency; underlying disease; and 
idiopathic short stature (ISS). Normal variants of 
growth were further categorized into familial short 
stature (FSS) and constitutional delay of growth and 
puberty (CDGP). FSS was defined as short stature on 
the height percentile which was within the normal 
range after correction for parents’ height. CDGP was 
defined as short stature with normal growth velocity, 
but delayed bone age and puberty. SGA was defined 
as a birth weight less than the 3rd percentile [3]. SGA 
without catch-up growth was defined as a birth weight 
less than the 3rd percentile with a body height less 
than the 3rd percentile at the age of 2 years. A detailed 
maternal history was reviewed in those with SGA 
without catch-up growth. Children whose growth ve-
locity was less than 4 cm/year, who had age-specific 
low serum IgF-1, and who had 2 years delayed bone 
age after at least 6 months of follow-up received ex-
ercise tests to screen for growth hormone deficiency. 
They were admitted to hospital if growth hormone was 
less than 10 ng/mL on a growth hormone provocation 
test. ISS was defined as short stature in which the 
cause could not be determined from the available 
data. All data were analyzed using Microsoft Excel.
3. Results
A total of 139 children were enrolled. The ratio of 
girls to boys was 3:2 (82:57). Seventy-seven children 
Table 1 — Etiology of short stature in 139 eastern 
Taiwanese children
 n (%)
Idiopathic 60 (43.2)
SGA without catch-up growth 14 (10.1)
Presence of underlying systemic disease 48 (34.5)
Normal variants of growth 11 (7.9)
  FSS 5
  CDGP 6
Growth hormone deficiency   6 (4.3)
SGA = small for gestational age; FSS = familial short stature; CDGP = 
constitutional delay of growth and puberty.
Table 2 — Underlying systemic diseases in eastern 
Taiwanese children with short stature
 n (%)
Neuromuscular disorders 23 (47.9)
 Epilepsy 12
 Cerebral palsy  9
 Congenital muscle atrophy  1
 Sturge-Weber syndrome  1
Gastrointestinal disorders   8 (16.7)
 Micronutrient deficiency  4
 Megacolon  2
 Enterocolitis  1
 Biliary atresia s/p Kasai procedure  1
Genetic diseases   8 (16.7)
 Multiple congenital anomalies  4
 Chromosome defect  4
Tumors 4 (8.3)
 Neurofibromatosis  2
 Neuroblastoma  1
 Wilms’ tumor s/p chemotherapy  1
Metabolic diseases 2 (4.2)
 3-methylglutaconic aciduria  2
Hematologic disorders 1 (2.1)
 Thalassemia  1
Miscellaneous 2 (4.2)
 Congenital cystic adenomatoid malformation  1
 Hypereosinophilia  1
Total 48 (100)
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also diagnosed with multiple congenital anomalies 
without chromosomal abnormalities or known major 
systemic diseases. No cases of Turner syndrome or 
Prader-Willi syndrome were found in this study. One 
case of hypereosinophilia was detected; however, no 
drug reaction or parasite infection was noted.
Fourteen children (10.1%) were diagnosed with SGA 
without catch-up growth. Maternal prenatal smoking 
and alcohol consumption were found in nine (64.3%) 
and eight (57.1%) cases, respectively.
Among those with normal variants of growth, five 
(3.6%) children had FSS with a normal-corrected height 
percentile, normal annual growth velocity, normal lab-
oratory studies and normal bone age study. Six 
(4.3%) children were diagnosed with CDGP with de-
layed bone age, and it was estimated that their final 
height would reach their genetic height. All of them 
are currently being followed-up.
Twenty-nine children underwent growth hormone 
provocation tests. Six (4.3%) were diagnosed as hav-
ing growth hormone deficiency and none of them was 
found to have hypothalamic-pituitary lesions. All of 
them were referred from school nurses. No cases of 
hypothyroidism were found in this study.
4. Discussion
ISS was the most common cause of short stature in 
eastern Taiwan, while normal variants of growth such 
as FSS and CDGP were the main causes in western 
Taiwan [4] and Pakistan [5]. The different results imply 
that lifestyle, as well as genetic and environmental 
factors play more pivotal roles in eastern Taiwan.
There was a lower prevalence of growth hormone 
deficiency compared with western Taiwan [4] and 
Pakistan [5]. No pituitary lesions or underlying ma-
lignancies were found in this population, perhaps 
because of the small population base or undetected 
cases. Continuous investigations are indicated. In this 
study, 83.3% of patients with growth hormone defi-
ciency were boys, which has not been previously re-
ported. The significance needs further clarification.
The percentage of children with SGA with poor 
progression (10.1%) was much higher than in western 
Taiwan (1.4%) [4] and Pakistan (4.2%) [5]. The etiology 
may be related to prenatal factors such as exposure 
to smoking and maternal alcohol consumption [6,7]. 
Thirty-eight children (including 40% of our SGA cases) 
were lost to follow-up from the outpatient clinic, which 
implies that psychosocial and economic issues, and 
difficulty reaching medical resources, should be ad-
dressed in this area.
Our study found many underlying chronic diseases 
that resulted in short stature. The mechanisms in-
volved in short stature may be related to underlying 
disease or be multifactorial without one specific cause. 
Malnutrition seems to be one of the most common 
causes reported. Deficiency of micronutrients, long-
term gastrointestinal disturbance [8], cerebral palsy 
[9], side effects of chemotherapy [9], tissue hypoxia, 
and iron overload related to endocrine complications 
have been reported [10]. In our patients, 8.6% were 
found to have epilepsy, although the factors contrib-
uting to growth failure remain unclear. Comprehensive 
dietary care and intensive management of underly-
ing disease are mandatory in patients with underlying 
disease.
Almost half of the children with short stature 
(44.6%) were discovered to have growth problems 
after attending primary school and were referred by 
school nurses. The six patients diagnosed with growth 
hormone deficiency were all referred by school nurses. 
This result indicates that we should not only continue 
to strengthen school nurses’ abilities to survey health, 
but also implement policies to educate parents on 
their children’s growth.
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